2/16/24 21:13 | 2/15/24 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Arkowitz David | MA | O | CFO | M.d | 0 | 0.00 | 0 | 11 | 6 | 182 | D | | | | | | | | | | | | | | |
2/16/24 21:13 | 2/16/24 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Arkowitz David | MA | O | CFO | S.d | -4 | 1.08 | 0 | -4 | -2 | 182 | D | | | | | | | | | | | | | | |
10/31/23 21:39 | 10/27/23 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Arkowitz David | MA | O | CFO | M.d | 0 | 0.00 | 0 | 13 | 8 | 176 | D | | | | | | | | | | | | | | |
10/31/23 21:39 | 10/30/23 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Arkowitz David | MA | O | CFO | S.d | -5 | 1.35 | 0 | -4 | -2 | 176 | D | | | | | | | | | | | | | | |
10/31/22 18:05 | 6/15/22 | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Arkowitz David | MA | O | CFO | M.d | 0 | 0.00 | 0 | 5 | 5 | 113 | D | | | | | | | | | | | | | | |
5/12/21 17:06 | 5/10/21 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Arkowitz David | MA | O | CFO | S | -16 | 7.23 | 0 | -2 | -1 | 221 | D | | | | | | | | | | | | | | |
1/7/21 17:50 | 1/5/21 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Arkowitz David | MA | O | CFO | S | -68 | 11.13 | 0 | -6 | -4 | 151 | D | | | | | | | | | | | | | | |
5/11/20 16:11 | 5/7/20 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Arkowitz David | MA | O | CFO | S | -26 | 10.88 | 0 | -2 | -2 | 117 | D | | | | | | | | | | | | | | |
1/7/20 16:31 | 1/3/20 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Arkowitz David | MA | O | CFO | S | 0 | 0.00 | 0 | -3 | -3 | 88 | D | | | | | | | | | | | | | | |
6/3/19 16:18 | 5/31/19 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Arkowitz David | MA | O | CFO | P | 28 | 11.05 | 0 | 3 | 3 | 89 | D | | | | | | | | | | | | | | |
5/15/19 16:05 | 5/13/19 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Arkowitz David | MA | O | CFO | P | 48 | 11.99 | 0 | 4 | 5 | 87 | D | | | | | | | | | | | | | | |
5/9/19 16:32 | 5/8/19 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Arkowitz David | MA | O | CFO | S | -23 | 10.06 | 0 | -2 | -3 | 83 | D | | | | | | | | | | | | | | |
11/13/18 09:14 | 11/9/18 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Arkowitz David | MA | O | CFO | P | 66 | 16.56 | 0 | 4 | 9 | 48 | D | | | | | | | | | | | | | | |
8/10/18 12:56 | 8/9/18 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Arkowitz David | MA | O | CFO | P | 94 | 23.42 | 0 | 4 | 10 | 44 | D | | | | | | | | | | | | | | |
8/7/17 16:02 | 8/4/17 | SBPH | Spring Bank Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Arkowitz David | MA | D | | P | 31 | 12.24 | 0 | 3 | 15 | 19 | D | | | | | | | | | | | | | | |
6/1/11 16:35 | 5/31/11 | AMAG | Amag Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Arkowitz David | MA | O | EVP,CFO, | P.a | 20 | 13.23 | 4 | 2 | 490 | 2 | D | -65 | -41 | 16 | 4 | 11 | 12 | 18 | 19 | 0 | -3 | 2 | -21 | -9 | -25 |
6/1/11 16:01 | 5/31/11 | AMAG | Amag Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Arkowitz David | MA | O | EVP,CFO, | P | 20 | 13.23 | 4 | 2 | 490 | 2 | D | -65 | -41 | 16 | 4 | 11 | 12 | 18 | 19 | 0 | -3 | 2 | -21 | -9 | -25 |
2/28/11 16:03 | 2/24/11 | AMAG | Amag Pharmaceuticals Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Arkowitz David | MA | O | EVP,CFO | S.d | -46 | 17.07 | 5 | -3 | -90 | 0 | D | -37 | -52 | -35 | 30 | 3 | 3 | 6 | 5 | -4 | -5 | -11 | -12 | -25 | -11 |
8/6/10 16:00 | 8/5/10 | AMAG | Amag Pharmaceuticals Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Arkowitz David | MA | O | EVP,CFO, | S.d | 0 | 0.00 | 14 | -16 | -93 | 1 | D | -25 | -30 | -18 | -3 | -12 | -13 | -17 | -2 | -1 | -7 | -18 | -46 | -43 | -49 |
6/1/10 16:00 | 5/28/10 | AMAG | Amag Pharmaceuticals Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Arkowitz David | MA | O | EVP,CFO, | P | 18 | 27.06 | 11 | 1 | 54 | 2 | D | -20 | -39 | -17 | -7 | -12 | 1 | 0 | 2 | 7 | 4 | 13 | -16 | -54 | -45 |
12/2/09 16:24 | 12/1/09 | AMAG | Amag Pharmaceuticals Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Arkowitz David | MA | O | CFO,Chie | P | 5 | 31.78 | 22 | 0 | 56 | 0 | D | -34 | 26 | -32 | -7 | 5 | -12 | -5 | -1 | -1 | 0 | -1 | -11 | -12 | -60 |
11/12/09 16:46 | 6/2/09 | AMAG | Amag Pharmaceuticals Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Arkowitz David | MA | O | CFO,Chie | P | 14 | 25.61 | 27 | 1 | | 0 | D | -26 | 110 | -19 | 0 | 4 | 19 | 10 | -2 | -2 | -8 | -14 | -11 | -25 | -65 |
11/12/09 16:46 | 11/12/09 | AMAG | Amag Pharmaceuticals Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Arkowitz David | MA | O | CFO,Chie | S | -194 | 43.42 | 27 | -4 | -94 | 0 | D | -26 | 110 | -19 | 0 | 4 | 19 | 10 | -2 | -2 | -8 | -14 | -11 | -25 | -65 |
6/13/08 09:43 | 6/11/08 | AMAG | Amag Pharmaceuticals Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Arkowitz David | MA | O | CFO,CBO, | P | 38 | 37.50 | 14 | 1 | 40 | 3 | D | 46 | -38 | -40 | 3 | -8 | -3 | -6 | 0 | 1 | 0 | -9 | 10 | -11 | 41 |
5/6/08 17:41 | 5/5/07 | AMAG | Amag Pharmaceuticals Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Arkowitz David | MA | O | CFO,Chie | P.d | 40 | 40.38 | 20 | 1 | 95 | 2 | D | 45 | -35 | -36 | -26 | 6 | 13 | 4 | -1 | -1 | 0 | -1 | 2 | -22 | 29 |
7/29/04 13:50 | 7/27/04 | IDIX | Idenix Pharmaceuticals Inc | | Health | Drug | Pharmaceutical Preparations | Arkowitz David | MA | O | CFO | P.d | 112 | 14.00 | 9 | 8 | New | 8 | D | | | | | | | | -4 | 1 | -3 | 7 | 52 | 54 | 111 |